J. Economou

发表

Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line

D. Morton, W. McBride, J. Economou, 1989, The Journal of experimental medicine.

Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.

L. Butterfield, S. Mehrotra, J. Economou, 2003, Cancer research.

Production of Interleukin-1 and Tumor Necrosis Factor by Human Peripheral Monocytes Activated by Periodontal Bacteria and Extracted Lipopolysaccharides

J. Economou, R. Lindemann, H. Rothermel, 1988, Journal of dental research.

Interleukin-3 in gene therapy of cancer.

C. Chiang, W. McBride, J. Economou, 1994, Folia biologica.

Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.

B. Bonavida, J. Economou, R. Koya, 2011, Cancer research.

Ionizing Radiation Affects Human MART-1 Melanoma Antigen Processing and Presentation by Dendritic Cells1

A. Ribas, L. Butterfield, K. Iwamoto, 2004, The Journal of Immunology.

Interleukin‐4 Downregulates Interleukin‐6 Production in Human Peripheral Blood Mononuclear Cells

S. Swisher, W. McBride, J. Economou, 1990, Journal of leukocyte biology.

Current D evelopments i n C ancer V accines a nd Cellular I mmunotherapy

A. Ribas, L. Butterfield, J. Economou, 2003 .

Current Deve lopments in Cancer Vacc ines and Cel lu lar Immunotherapy

A. Ribas, L. Butterfield, J. Economou, 2003 .

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

A. Ribas, L. Butterfield, W. McBride, 1999, Cancer research.

α-Fetoprotein-specific Genetic Immunotherapy for Hepatocellular Carcinoma

A. Ribas, L. Butterfield, W. McBride, 1999 .

Identification and characterization of a low-affinity granulocyte-macrophage colony-stimulating factor receptor on primary and cultured human melanoma cells.

G. Widhopf, D. Golde, G. Baldwin, 1991, Blood.

Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma.

A. Ribas, L. Butterfield, L. Gordon, 2004, Controlled clinical trials.

Determinant spreading and tumor responses after peptide-based cancer immunotherapy.

A. Ribas, L. Butterfield, J. Economou, 2003, Trends in immunology.

Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.

R. Elashoff, A. Ribas, A. Cochran, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial.

R. Figlin, C. Tso, W. McBride, 1996, The Journal of clinical investigation.

Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor.

J. Economou, R. Nazarian, A. Jazirehi, 2014, American journal of clinical and experimental immunology.

Tumor Antigen-Specific T Cell Responses in Hepatocellular Cancer Patients

A. Ribas, L. Butterfield, J. Economou, 2006 .

Cancer immunotherapy using gene-modified dendritic cells.

A. Ribas, L. Butterfield, J. Economou, 2002, Current gene therapy.

Prognostic significance of melanoma arising in the scalp.

D. Morton, J. Economou, R. Essner, 1988, American journal of surgery.

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade

B. Comin-Anduix, A. Ribas, A. Cochran, 2009, Clinical Cancer Research.

Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.

A. Ribas, L. Gordon, J. Gómez-Navarro, 2007, American journal of ophthalmology.

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.

A. Ribas, S. Rosenberg, U. Hegde, 2010, Clinical immunology.

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells.

A. Ribas, L. Butterfield, W. McBride, 2000, Journal of immunotherapy.

Genetic immunotherapy for cancer.

A. Ribas, L. Butterfield, J. Economou, 2000, The oncologist.

Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors

K. Black, D. Boothman, B. Badie, 1998, Journal of Neuro-Oncology.

Cells in the Absence of CD8-Positive Cells Enhanced Tumor Responses to Dendritic

J. Wargo, A. Ribas, W. McBride, 2013 .

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells

J. Wargo, A. Ribas, L. Butterfield, 2005, Cancer Gene Therapy.

Broad antitumor protection by dendritic cells administered to CD8α knock out mice

B. Comin-Anduix, A. Ribas, W. McBride, 2006, Cancer Immunology, Immunotherapy.

Enhanced Tumor Responses to Dendritic Cells in the Absence of CD8-Positive Cells1

J. Wargo, A. Ribas, L. Butterfield, 2004, The Journal of Immunology.

T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.

A. Ribas, L. Butterfield, W. McBride, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

A. Ribas, L. Butterfield, W. McBride, 1999, Cancer research.

Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy

J. Wargo, A. Ribas, L. Butterfield, 2004, Journal of immunotherapy.

Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays

B. Comin-Anduix, A. Ribas, A. Gualberto, 2006, Clinical Cancer Research.

Immunomodulation by imiquimod in patients with high-risk primary melanoma

A. Ribas, J. Economou, H. Vargas, 2011, The Journal of investigative dermatology.

RETROVIRAL‐MEDIATED GENE TRANSFER INTO RAT EXPERIMENTAL LIVER TRANSPLANT

M. Csete, R. Busuttil, A. Miller, 1994, Transplantation.

Cytokine-mediated gene therapy for cancer

K. Hunt, W. McBride, A. Miller, 1994, Annals of Surgical Oncology.

Overview of biological response modifiers.

J. Economou, R. Essner, E. Staren, 1989, Seminars in surgical oncology.

The adenoviral transcription factor, E1A 13S, trans-activates the human tumor necrosis factor-alpha promoter.

J. Economou, K. Rhoades, S. Golub, 1996, Virus research.

Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes.

W. McBride, J. Economou, R. Essner, 1990, Cancer research.

Interleukin‐1 and tumor necrosis factor production by tumor‐associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients

D. Morton, E. Holmes, J. Economou, 1988, International journal of cancer.

Actinobacillus actinomycetemcomitans and Bacteroides gingivalis activate human peripheral monocytes to produce interleukin-1 and tumor necrosis factor.

J. Economou, R. Lindemann, 1988, Journal of periodontology.

Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy.

W. McBride, S. Dubinett, D. Kelley, 1993, Immunological investigations.

Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.

A. Ribas, L. Butterfield, W. McBride, 2000, Cancer research.

Interleukin‐4 inhibits the expression of tumour necrosis factors α and β, interleukins‐1 β and ‐6 and interferon‐γ

J. Economou, K. Rhoades, Jeffrey D. Lee, 1995 .

Cancer Research in the 21st Century.

D. Slamon, J. Economou, Michael E. Phelps, 2016, Annals of surgery.

PRESIDENTIAL FORUM Cancer Research in the 21st Century

D. Slamon, J. Economou, Michael E. Phelps, 2016 .

CD4+CD25− T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model1

D. Baltimore, B. Comin-Anduix, A. Ribas, 2008, The Journal of Immunology.

Function in a Human Melanoma Model MHC Class I-Restricted Cytolytic Effector TCR Synthesize Th 1 Cytokines and Exhibit MHC Class I-Restricted Epitope-Specific T Cells Transduced to Express − CD 25 + CD 4 Baltimore and Bijay Mukherji

D. Baltimore, B. Comin-Anduix, A. Ribas, 2008 .

Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma

D. Baltimore, A. Ribas, O. Witte, 2010, Pigment cell & melanoma research.

Transduction of murine and human tumors using recombinant adenovirus vectors

K. Hunt, S. Swisher, W. McBride, 2006, Annals of Surgical Oncology.

Modification of tumor microenvironment by cytokine gene transfer.

R. Syljuåsen, J. Hong, C. Chiang, 1995, Acta oncologica.

Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity.

W. McBride, S. Dubinett, D. Kelley, 1992, Cancer research.

Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs

J. Economou, A. Jazirehi, 2012, Molecular Cancer Therapeutics.

Preclinical Development Proteasome Inhibition Blocks NFk B and ERK 1 / 2 Pathways , Restores Antigen Expression , and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs

J. Economou, A. Jazirehi, Ali R. Jazirehi, 2012 .

T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy

T. Chatila, W. McBride, D. Vo, 2012, Journal of Translational Medicine.

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.

A. Ribas, L. Butterfield, W. McBride, 1997, Human gene therapy.

Nuclear magnetic resonance studies of cancer. IV. Correlation of water content with tissue relaxation times.

J. Economou, J. Eggleston, D. Hollis, 1974, Journal of the National Cancer Institute.

Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures1

L. Butterfield, P. Frost, B. Bonavida, 2001, The Journal of Immunology.

Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions.

L. Butterfield, J. Economou, R. Lau, 1997, Gene.

Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.

L. Butterfield, L. Li, J. Economou, 1998, Cancer research.

Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer

A. Ribas, L. Butterfield, J. Economou, 2007, Cancer Immunology, Immunotherapy.

NK and CD 4 Cells Collaborate to Protect against Melanoma Tumor Formation in the Brain 1

L. Liau, A. Ribas, H. Soto, 2006 .

A methods study to define the performance specifications of MHC tetramer assays for immune monitoring of tumor immunotherapy.

B. Comin-Anduix, A. Ribas, A. Gualberto, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity

S. Swisher, D. Hoon, D. Morton, 2005, Cancer Immunology, Immunotherapy.

Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells

A. Ribas, L. Butterfield, W. McBride, 1999, Cancer Gene Therapy.

Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.

A. Ribas, L. Butterfield, W. McBride, 1998, Journal of immunology.

Adenovirus Lymphocytes by Dendritic Cells Transduced Generation of Melanoma-Specific Cytotoxic T

A. Ribas, L. Butterfield, W. McBride, 1998 .

Soft tissue sarcomas of the extremity and retroperitoneum: advances in management.

V. Sondak, J. Economou, F. Eilber, 1991, Advances in surgery.

T Cell Responses to HLA-A*0201-Restricted Peptides Derived from Human α Fetoprotein1

A. Ribas, L. Butterfield, W. McBride, 2001, The Journal of Immunology.

IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

D. Morton, W. McBride, J. Economou, 1989, Journal of immunology.

Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.

L. Butterfield, M. Stolina, M. Dohadwala, 2000, Human gene therapy.

alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.

A. Ribas, L. Butterfield, W. McBride, 2001, Cancer research.

Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

A. Ribas, L. Butterfield, W. McBride, 1997, Cancer research.

Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene–modified dendritic cell vaccines

A. Ribas, L. Ignarro, L. Butterfield, 2002, Cancer Gene Therapy.

Mechanisms of tumor immunity: the role of antibody and nonimmune effectors.

G. Pasternack, J. Economou, R. Johnson, 1978, Progress in allergy.

Therapy of a murine lymphoma with tumor-specific antiserum in combination with adriamycin, cyclophosphamide, or L-asparaginase.

J. Economou, 1980, Surgery.

Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.

A. Ribas, L. Butterfield, W. McBride, 2000, Cancer research.

Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-4 Differentially Regulate the Human Tumor Necrosis Factor-α Promoter Region

J. Economou, K. Rhoades, S. Cai, 1995 .

Human gene marker/therapy clinical protocols.

R. Haubrich, K. Cornetta, J. Roth, 1999, Human gene therapy.

Tumournecrosis factor production byIL-2-activated macrophages invitro andinvivo

D. Morton, E. Holmes, J. Economou, 1989 .

CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.

A. Ribas, L. Butterfield, W. McBride, 2001, Cancer research.

TNF-α and IFN-γ reverse IL-4 inhibition of lymphokine-activated killer cell function

S. Swisher, E. Holmes, J. Economou, 1990 .

p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.

A. Ribas, L. Butterfield, W. McBride, 1999, Cancer research.

Selective and Nonselective Replication of an E 1 B-deleted Adenovirus in Hepatocellular Carcinoma 1

A. Ribas, L. Butterfield, W. McBride, 1999 .

Observations on a possible association between the acid mucopolysaccharides and lysozyme

J. Economou, 1971, Journal of surgical oncology.

Nuclear magnetic resonance studies of cancer. V. Appearance and development of a tumor systemic effect in serum and tissues.

H. Morris, J. Economou, J. Eggleston, 1974, Journal of the National Cancer Institute.

NK and CD4 Cells Collaborate to Protect against Melanoma Tumor Formation in the Brain1

L. Liau, A. Ribas, H. Soto, 2006, The Journal of Immunology.

cultured human melanoma cells macrophage colony-stimulating factor receptor on primary and Identification and characterization of a low-affinity granulocyte

D. Golde, J. Economou, George, 2003 .

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

A. Ribas, L. Butterfield, R. Finn, 2006, Clinical Cancer Research.

A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.

A. Ribas, L. Butterfield, R. Finn, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

Management of primary germ cell tumors of the mediastinum.

D. Trump, E. Holmes, J. Economou, 1982, The Journal of thoracic and cardiovascular surgery.

Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

J. Economou, B. Lewis, D. Hohn, 1986, Cancer.

Human gene marker/therapy clinical protocols.

K. Cornetta, J. Roth, R. Crystal, 1996, Human gene therapy.

Human Dendritic Cell Maturation by Adenovirus Transduction Enhances Tumor Antigen-Specific T-Cell Responses

A. Ribas, L. Butterfield, W. McBride, 2004, Journal of immunotherapy.

Technical details of intraoperative lymphatic mapping for early stage melanoma.

D L Morton, A. Cochran, D. Morton, 1992, Archives of surgery.

Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

K. Cornetta, A. Ishiyama, J. Heath, 2014, Clinical Cancer Research.

Immunotherapy of cancer with antibody.

G. Pasternack, J. Economou, R. Johnson, 1976, Science.

Soft tissue sarcomas.

V. Sondak, D. Morton, J. Economou, 2004, Seminars in surgical oncology.

Interleukin 32 expression in human melanoma

T. Graeber, A. Ribas, L. Butterfield, 2019, Journal of Translational Medicine.

ANTIBODY-MEDIATED SUPPRESSION OF GRAFTED LYMPHOMA IV . Influence of Time of Tumor Residency In Vivo and Tumor Size Upon the Effectiveness of Suppression by Syngeneic Antibody

G. Pasternack, J. Economou, R. Johnson, 2003 .

Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma

A. Ribas, L. Butterfield, J. Economou, 2008, Journal of immunotherapy.

Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7.

W. McBride, S. Dubinett, S. Dhanani, 1995, Journal of the National Cancer Institute.

Immunotherapy Resistance by Inflammation-Induced Dedifferentiation.

B. Comin-Anduix, A. Ribas, A. Cochran, 2018, Cancer discovery.

Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products

D. Baltimore, B. Comin-Anduix, A. Ribas, 2018, Journal of immunotherapy.

Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model.

K. Hunt, K. Black, B. Badie, 1994, Neurosurgery.

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

B. Comin-Anduix, A. Ribas, L. Camacho, 2008, Journal of Translational Medicine.

In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector.

K. Hunt, A. Belldegrun, S. Swisher, 1996, Cancer gene therapy.

Current developments in cancer vaccines and cellular immunotherapy.

Antoni Ribas, A. Ribas, L. Butterfield, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effects of cytokine gene transfer into tumors on host cell infiltration and regression.

R. Syljuåsen, C. Chiang, W. McBride, 1996, Anticancer research.

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

A. Ribas, A. Cochran, Stephen Mok, 2011, Clinical Cancer Research.

The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines.

J. Economou, K. Rhoades, S. Golub, 1992, The Journal of biological chemistry.

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

F. Marincola, A. Ribas, E. Wang, 2009, Cancer Research.

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

F. Marincola, B. Comin-Anduix, A. Ribas, 2009, Clinical Cancer Research.

Cancer Therapy: Clinical Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

F. Marincola, B. Comin-Anduix, A. Ribas, 2009 .

T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3

T. Chatila, W. McBride, J. Economou, 2011, Journal of hematology & oncology.

T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp 3

T. Chatila, W. McBride, J. Economou, 2011 .

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein.

A. Ribas, L. Butterfield, W. McBride, 2000, Molecular immunology.

Radiation enhances regulatory T cell representation.

J. DeMarco, N. Agazaryan, W. McBride, 2011, International journal of radiation oncology, biology, physics.

Antigen presentation by MART‐1 adenovirus‐transduced interleukin‐10‐polarized human monocyte‐derived dendritic cells

L. Butterfield, S. Mehrotra, S. Chattopadhyay, 2004, Immunology.

A comparison of gene transfer methods in human dendritic cells.

M. Roth, L. Butterfield, W. McBride, 1997, Cancer gene therapy.

Histone Deacetylase Inhibitor Sensitizes Apoptosis-Resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL/DR5 Pathway

J. Economou, S. Kurdistani, A. Jazirehi, 2014, The Journal of Immunology.

Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.

David Baltimore, Antoni Ribas, James R Heath, 2013, Cancer discovery.

Lymphocyte-activating factor. I. Generation and physicochemical characterization.

J. Economou, H. Shin, 1978, Journal of immunology.

Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.

Michael L Kaufman, D. Baltimore, A. Ribas, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo.

D. Morton, W. McBride, E. Holmes, 1989, Immunology.

Molecular mechanisms of interleukin 2 induction of tumor necrosis factor gene expression in macrophages

W. McBride, E. Holmes, J. Economou, 1988 .

Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran

R. Elashoff, C. Hoh, S. Barsky, 1998, Cancer.

Interleukin-6 production by human melanoma cell lines.

D. Morton, W. McBride, J. Economou, 1992, Lymphokine and cytokine research.

Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector.

S. Barsky, J. Economou, M. Nguyen, 1998, Anticancer research.

Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma.

A. Ribas, S. Mehrotra, J. Economou, 2009, Clinics in dermatology.

Mechanisms of Tumor Immunity: the Role of Antibody and Nonimmune Effectors1

G. Pasternack, J. Economou, Hyun S. Shin, 1978 .

Tumor Immunology and Immunotherapy

J. Tomlinson, J. Yang, J. Economou, 2012 .

Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity.

S. Swisher, D. Hoon, D. Morton, 1991, Cancer immunology, immunotherapy : CII.

Gender bias in biomedical research.

J. Economou, 2014, Surgery.

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients

L. Butterfield, D. Geller, J. Economou, 2014, Journal of Translational Medicine.

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.

A. Ribas, L. Butterfield, W. McBride, 2001, Journal of immunology.

Immunosensitization of Tumor Cells to Dendritic Cell-Activated Immune Responses with the Proteasome Inhibitor Bortezomib (PS-341, Velcade)1

B. Comin-Anduix, A. Ribas, W. McBride, 2006, The Journal of Immunology.

Bone Marrow Transplantation in Cancer Therapy: Inactivation by Antibody and Complement of Tumor Cells in Mouse Syngeneic Marrow Transplants 1

J. Economou, G. Santos, H. Kaizer, 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Changes in Intratumoral Immune Cell Infiltrates, Foxp3 and Indoleamine 2, 3-Dioxygenase (IDO) Expression With the CTLA4 Blocking MAB CP-675,206

A. Ribas, J. Economou, J. Glaspy, 2006 .

Interleukin 32 expression in human melanoma

T. Graeber, A. Ribas, L. Butterfield, 2019, Journal of translational medicine.

Nuclear magnetic resonance studies of several experimental and human malignant tumors.

J. Economou, J. Eggleston, L. Parks, 1973, Cancer research.

IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.

J. Economou, S. Colquhoun, S. Golub, 1993, Journal of Surgical Research.

Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.

D. Morton, W. McBride, J. Economou, 1990, Journal of clinical & laboratory immunology.

A Histone Deacetylase Inhibitor (HDACI) Sensitizes B16 Melanoma to Adoptive Transfer (AT) Immunotherapy

A. Ribas, D. Vo, J. Economou, 2006 .

TNF-alpha and IFN-gamma reverse IL-4 inhibition of lymphokine-activated killer cell function.

S. Swisher, E. Holmes, J. Economou, 1990, Cellular Immunology.

Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.

M. Roth, W. McBride, S. Dubinett, 1996, Cancer gene therapy.

This information is current as Function in a Human Melanoma Model MHC Class I-Restricted Cytolytic Effector TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Epitope-Specific T Cells Transduced to Express - CD4+CD25

S. Mehrotra, J. Economou, D. Dorsky, 2013 .

Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs

J. Economou, A. Jazirehi, Ali R. Jazirehi, 2012, Molecular Cancer Therapeutics.

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

A. Ribas, A. Cochran, Stephen Mok, 2011, Clinical Cancer Research.

Cancer Research in the 21st Century.

D. Slamon, J. Economou, Michael E. Phelps, 2016, Annals of surgery.

Engines of Discovery and Innovation.

J. Economou, 2016, Annals of surgery.

Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824.

F. Marincola, A. Ribas, E. Wang, 2009, Cancer research.

Histone Deacetylase Inhibitor Sensitizes Apoptosis-Resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL/DR5 Pathway

J. Economou, S. Kurdistani, Ali R. Jazirehi, 2014, The Journal of Immunology.